Published in World J Surg Oncol on January 27, 2010
The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study. Ann Surg Oncol (2015) 0.82
Ductal carcinoma in situ of the breast: a surgical perspective. Int J Surg Oncol (2012) 0.80
Ductal carcinoma in situ and sentinel lymph node biopsy. J Breast Cancer (2011) 0.80
Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ? Ann Surg Oncol (2016) 0.79
Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen. World J Surg Oncol (2015) 0.79
Sentinel lymph node biopsy in patients with breast ductal carcinoma in situ: Chinese experiences. Oncol Lett (2015) 0.75
Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ. World J Clin Oncol (2016) 0.75
Breast segmentectomy with rotation mammoplasty as an oncoplastic approach to extensive ductal carcinoma in situ. World J Surg Oncol (2016) 0.75
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
The sentinel node in breast cancer--a multicenter validation study. N Engl J Med (1998) 8.48
Ductal carcinoma in situ of the breast. N Engl J Med (2004) 6.63
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol (2007) 4.05
Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer (2006) 3.86
A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg (2008) 3.14
Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg (2002) 2.03
Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol (2006) 1.73
Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg (2008) 1.67
Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol (1999) 1.24
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg (2008) 1.20
Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol (1995) 1.13
Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg (2005) 1.07
Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat (2006) 1.03
The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer (2004) 1.01
Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast (2006) 0.96
Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol (2007) 0.93
Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer (2005) 0.91
The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol (2008) 0.85
The effect of an old surgical scar on sentinel node mapping in patients with breast cancer: a report of five cases. Eur J Surg Oncol (2005) 0.85
Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast. Radiol Med (2007) 0.83
The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol (2006) 0.82
Sentinel lymph node biopsy in women with pT1a or "microinvasive" breast cancer. Breast (2008) 0.79
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol (2008) 2.90
One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res (2007) 2.36
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes. Eur J Cancer (2012) 2.01
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast (2007) 1.64
Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg (2006) 1.53
Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res (2009) 1.52
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer (2008) 1.37
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer (2006) 1.28
Flare-up of dermatomyositis along with recurrence of breast cancer. Breast J (2007) 1.25
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
A case of carcinosarcoma of the breast. Breast Cancer (2005) 1.18
Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma (2010) 1.18
Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol (2002) 1.17
Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood (2010) 1.13
Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging (2007) 1.11
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer (2005) 1.10
General rules for clinical and pathological recording of breast cancer 2005. Breast Cancer (2005) 1.08
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer. Jpn J Clin Oncol (2011) 1.07
Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol (2010) 1.06
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast Cancer (2006) 1.05
Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer (2005) 1.04
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer (2011) 1.03
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Cancer Sci (2013) 1.03
Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer (2003) 1.00
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer (2006) 0.99
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer (2009) 0.99
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer (2006) 0.99
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol (2009) 0.99
Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis. Cancer Sci (2013) 0.98
Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma. Pathol Int (2011) 0.97
Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat (2007) 0.96
Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes. Breast Cancer (2009) 0.94
A unique fibrous tumor of the ovary: fibrosarcoma or mitotically active cellular fibroma? Anticancer Res (2008) 0.93
Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan. Acta Med Okayama (2010) 0.92
A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer (2003) 0.92
Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix. Gynecol Oncol (2004) 0.91
MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes. Breast Cancer (2010) 0.90
Present state of and problems with core needle biopsy for non-palpable breast lesions. Breast Cancer (2006) 0.90
High levels of DJ-1 protein in nipple fluid of patients with breast cancer. Cancer Sci (2012) 0.90
Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging. Ann Nucl Med (2004) 0.90
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer (2002) 0.90
Expression of cyclooxygenase-2 in malignant and benign breast tumors. Anticancer Res (2003) 0.90
A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer (2013) 0.89
Assessment of hormone receptor status in breast cancer. Pathol Int (2007) 0.89
Spontaneous " healing" of breast cancer. Breast Cancer (2005) 0.89
Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer. J Hum Genet (2007) 0.88
Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray. Cancer Sci (2004) 0.88
A case of successful pregnancy after treatment of invasive cervical cancer with systemic chemotherapy and conization. Gynecol Oncol (2005) 0.88
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol (2007) 0.88
Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy. Gynecol Oncol (2010) 0.88
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard. Am J Clin Pathol (2008) 0.87
Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer (2005) 0.87
Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy. Breast Cancer (2013) 0.87
Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci (2014) 0.87